| Acupuncture in Herpes Zoster Neuralgia (ACUZoster) (NCT00885586) | Dominik Irnich | 2008-11-01 |
| Zostavax® at Minimum Release Specification Approaching Expiry (V211-044) (NCT00681031) | Merck Sharp & Dohme LLC | 2008-05-14 |
| The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting (NCT00689013) | University of Tennessee | 2008-02-01 |
| Activation of Alternative Cellular Energy (ACE) Pathway in the Therapy of Herpes Virus Infections (NCT00642785) | Institute of Progressive Medicine | 2008-01-01 |
| Dose-finding Study of ASP2151 in Subjects With Herpes Zoster (NCT00487682) | Astellas Pharma Inc | 2007-11-13 |
| A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002) (NCT00535236) | Merck Sharp & Dohme LLC | 2007-11-02 |
| A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster (NCT00831103) | Epiphany Biosciences | 2007-11-01 |
| A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN) (NCT00576108) | Kalypsys, Inc. | 2007-11-01 |
| ZOSTAVAX™ in Patients on Chronic/Maintenance Corticosteroids (V211-017) (COMPLETED) (NCT00546819) | Merck Sharp & Dohme LLC | 2007-10-01 |
| ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020) (NCT00550745) | Merck Sharp & Dohme LLC | 2007-09-01 |
| VZV PCR Sampling Validation Study (NCT00501670) | GlaxoSmithKline | 2007-08-01 |
| Month 30 & 42 Extension Studies of CRD-004 Primary Study (NCT00492648) | GlaxoSmithKline | 2007-06-25 |
| ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED) (NCT00535730) | Merck Sharp & Dohme LLC | 2007-06-01 |
| Measuring Herpes Zoster and PHN Associated Burden of Illness and Health Care Utilization Costs in Thailand (NCT00526864) | Mahidol University | 2007-05-01 |
| An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN). (NCT00492323) | SK Life Science, Inc. | 2007-03-01 |
| Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects (NCT00434577) | GlaxoSmithKline | 2007-02-14 |
| Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions (NCT01132716) | Roxane Laboratories | 2006-09-01 |
| Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions (NCT01132729) | Roxane Laboratories | 2006-09-01 |
| Study to Find Out if Therapy With the Drug Pregabalin Relieves Pain During Shingles Compared With Placebo (NCT00352651) | University of California, San Francisco | 2006-06-01 |
| A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014) (NCT00322231) | Merck Sharp & Dohme LLC | 2006-05-01 |
| Study of NGX-4010 for the Treatment of Postherpetic Neuralgia (NCT00300222) | NeurogesX | 2006-03-01 |
| Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food (NCT02852876) | Astellas Pharma Europe Ltd. | 2005-09-01 |
| A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011) (NCT00231816) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN) (NCT00233155) | NeurogesX | 2005-08-01 |
| A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED) (NCT00130793) | Merck Sharp & Dohme LLC | 2005-08-01 |
| Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection (NCT00098046) | Novartis | 2005-07-01 |
| Study of NGX-4010 for the Treatment of Postherpetic Neuralgia (NCT00115310) | NeurogesX | 2005-06-01 |
| Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain (NCT00034710) | NeurogesX | 2002-03-01 |
| Reduction of Postherpetic Neuralgia in Herpes Zoster (NCT01250561) | Center for Clinical Studies, Texas | 2002-02-01 |
| Shingles: Immune Effects of Tai Chi (NCT00118885) | National Institute on Aging (NIA) | 2001-07-01 |
| Shingles Prevention Study (NCT00007501) | US Department of Veterans Affairs | 1998-11-01 |
| Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster (NCT00006131) | National Center for Research Resources (NCRR) | 1997-01-01 |
| A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED) (NCT01077804) | Merck Sharp & Dohme LLC | 1995-06-01 |
| Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic Neuralgia (NCT00004390) | National Center for Research Resources (NCRR) | 1995-02-01 |
| Dextromethorphan Versus Placebo for Neuropathic Pain (NCT00001344) | National Institute of Dental and Craniofacial Research (NIDCR) | 1993-03-01 |
| An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain (NCT00089557) | NeurogesX | |
| NGX-4010 for the Treatment of Postherpetic Neuralgia (NCT00061776) | NeurogesX | |
| Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain (NCT00082316) | NeurogesX | |